Relative Bioavailability of Tiotropium and Salmeterol After Inhalation of a Fixed Combined Dose Compared to Monocomponents in Healthy Male Volunteers

Condition:   Healthy
Interventions:   Drug: Tiotropium/Salmeterol;   Drug: Serevent® Diskus®;   Drug: Spiriva®
Sponsor:   Boehringer Ingelheim
Completed – verified September 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.